FabI inhibitors (Oscient Pharmaceutials)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFabI inhibitors (Oscient Pharmaceutials)
Drug Alias NameFabI inhibitors (Genome Therapeutics)GTC-0118681GTC-0289602GTC-0053231GTC-4061
ClassificationSmall molecules
Mechanisms of ActionBacterial lipid synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOscient Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOscient Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A